Whole Slide Imaging Market expected to grow at a CAGR of 18.1% and projected to reach US$ 1,582.12 million by 2027
The whole slide imaging market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027.
Whole slide imaging technology deals with the acquisition of high-speed, high-resolution slide images for pathology workflow. The technology is also known as virtual pathology and plays major role in the digital pathology. Whole slide imaging is responsible for image archiving and sharing. In addition, these images can also utilized for diagnosis by pathologists by generating digital workflow. Technological advancements in whole slide imaging and increasing adoption of digital pathology is anticipated to drive the growth of whole slide imaging market during the forecast period.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00007740/
- 3DHISTECH Ltd.
- Indica Labs
- Inspirata, Inc.
- Koninklijke Philips N.V.
- Hamamatsu Photonics K.K.
- Danaher (Leica Biosystems)
- Mikroscan Technologies, Inc
- Visiopharm AS.
- Akoya Biosciences, Inc.
Continual advancements in computational algorithms and image capturing technologies are making a constructive impact on the development of whole slide imaging technologies. Improvements in this technology are leading to a better throughput, error reduction, quick and efficient image capturing, image archiving, and image sharing. For instance, in December 2019, Molecular Machines & Industries (MMI) launched MMI CellScan, an advanced whole slide imaging technology for digital pathology. The company introduced this system at Digital Pathology Congress, the UK. As per the company, this system enables quick scan and magnification with different imaging modes. Additionally, in March 2019, NanoString announced launch of GeoMx Digital Spatial Profiler, a next generation whole slide imaging technology for detailed spatial profiling of nucleic acid molecules. The system was introduced at the American Association of Cancer Research Conference 2019. Further, in October 2019, Olympus Corporation announced launch of its SLIDEVIEW VS200, an advanced slide scanner for high-resolution image acquisition. The equipment is capable of high-speed data acquisition and image processing of tissue samples as well as single cell. Such technological developments are estimated to drive the adoption of whole slide imaging systems, which would eventually boost the market growth during the forecast period.
Based on type, the whole slide imaging market is segmented into hardware, software, and services. The hardware segment is further sub-segmented as scanners, microscopes, and cameras. The hardware segment held the largest share of the market in 2019. Also, the same segment is estimated to register the highest CAGR of 18.6% in the market during the forecast period. The hardware segment in the global whole slide imaging market includes microscope and input/output devices. Increasing number of product approvals and introductions are likely to offer significant growth opportunity for the segment. For instance, in May 2019, Leica Biosystems received FDA approval for its Aperio AT2 DX System, digital pathology system. The system is compatible with whole slide imaging systems. Such product launches are estimated to drive the segment growth.
Whole Slide Imaging Market – by Type
- Image Management Systems
Whole Slide Imaging Market – by Application
Whole Slide Imaging Market – by End User
- Academic Research Institutes
- Pharmaceutical and Biopharmaceutical Companies
Based on application, the whole slide imaging market is segmented into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment held the largest share of the market in 2019 however, immunohistochemistry segment is estimated to register the highest CAGR in the market during the forecast period. International players are also focusing on the establishment of partnerships and collaborations to consolidate their presence in telepathology market. For instance, in October 2018, Nikon and OptraSCAN announced strategic collaboration to extend its telepathology customer reach in North America. Such strategic developments are anticipated to offer constructive environment for segment growth
End User-Based Insights
Based on end user, the whole slide imaging market is segmented into hospitals, pharmaceutical and biopharmaceutical companies, laboratories, and academic research institutions. The academic research institutes held the largest share of the market in 2019, however, pharmaceutical and biopharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period. The research & academic institutes provide information regarding the process of working with various biotechnological researches, such as registering and storing chemical and liquid samples. For instance, Leibniz Research Institute for Molecular Pharmacology at the Forschungsverbund Berlin eV (FMP) (Germany) is responsible for the intake, retrieval, storage, formatting, and shipping of all molecule samples associated with therapeutics projects
Various companies operating in the whole slide imaging market perform strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the growing demand from end users.
- Website: Whole Slide Imaging Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Hardware, Software, and Services); Application (Telepathology, Cytopathology, Immunohistochemistry, and Hematopathology); End User (Hospitals, Pharmaceutical and Biopharmaceutical Companies, Laboratories, and Academic Research Institutes)